Are There Static-Structural Biomarkers for Glaucoma with OCT?

Area of Science:

• Ophthalmology
• Medical Imaging
• Artificial Intelligence

Background:

• Glaucoma causes progressive optic nerve atrophy and visual field loss.
• Early diagnosis of glaucoma is essential due to irreversible optic nerve damage.
• Current optical coherence tomography (OCT) biomarkers for optic atrophy lack specificity in differentiating glaucoma from other optic neuropathies.

Purpose of the Study:

• To explore the potential of artificial intelligence (AI) in analyzing structural OCT images for improved glaucoma diagnosis.
• To investigate if AI-based biomarkers derived from OCT can be more specific than current thickness measurements for neuronal tissues.

Main Methods:

• Utilizing structural optical coherence tomography (OCT) imaging.
• Applying artificial intelligence (AI) algorithms to analyze OCT images.
• Correlating OCT parameters with other diagnostic variables.

Main Results:

• Structural OCT can identify optic atrophy, but specificity in differential diagnosis remains a challenge.
• Combining OCT parameters and correlating them with other variables aids glaucoma diagnosis.
• AI analysis of structural OCT images shows promise for superior and more specific biomarker identification compared to simple thickness measurements.

Conclusions:

• Artificial intelligence holds significant potential to enhance the specificity of OCT-based biomarkers for glaucoma diagnosis.
• AI-driven analysis of OCT images may overcome limitations of current methods in detecting and differentiating optic nerve atrophy.
• Further research into AI applications in OCT imaging is warranted for advancing glaucoma diagnostics.